PANACEA LIFE SCIENCES HOLDINGS, INC. Quarterly Cost of Revenue in USD from Q1 2018 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
Panacea Life Sciences Holdings, Inc. quarterly/annual Cost of Revenue history and growth rate from Q1 2018 to Q1 2024.
  • Panacea Life Sciences Holdings, Inc. Cost of Revenue for the quarter ending March 31, 2024 was $390K, a 13.6% decline year-over-year.
  • Panacea Life Sciences Holdings, Inc. Cost of Revenue for the twelve months ending March 31, 2024 was $1.2M, a 8.73% decline year-over-year.
  • Panacea Life Sciences Holdings, Inc. annual Cost of Revenue for 2023 was $1.26M, a 2.64% increase from 2022.
  • Panacea Life Sciences Holdings, Inc. annual Cost of Revenue for 2022 was $1.23M, a 19% decline from 2021.
  • Panacea Life Sciences Holdings, Inc. annual Cost of Revenue for 2021 was $1.52M, a 78.4% decline from 2020.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Quarterly (USD)
Cost of Revenue, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $1.2M $390K -$61.6K -13.6% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-06
Q4 2023 $1.26M $414K +$200K +93.3% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-01
Q3 2023 $1.06M $201K -$118K -36.9% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $1.18M $196K -$135K -40.8% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-15
Q1 2023 $1.32M $452K +$85.8K +23.4% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-06
Q4 2022 $1.23M $214K -$422K -66.3% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-01
Q3 2022 $1.65M $319K +$13.9K +4.56% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $1.64M $332K +$82.9K +33.3% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-15
Q1 2022 $1.56M $366K +$36.3K +11% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q4 2021 $1.52M $636K +$540K +562% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-30
Q3 2021 $980K $305K -$2.6M -89.5% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $3.58M $249K -$2.73M -91.6% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 $6.31M $330K -$713K -68.4% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
Q4 2020 $7.02M $96K -$1.73M -94.7% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-31
Q3 2020 $8.75M $2.91M +$2.81M +2794% Jul 1, 2020 Sep 30, 2020 10-Q/A 2021-12-20
Q2 2020 $5.95M $2.98M +$2.98M Apr 1, 2020 Jun 30, 2020 10-Q/A 2021-12-20
Q1 2020 $2.97M $1.04M +$1.03M +8174% Jan 1, 2020 Mar 31, 2020 10-Q/A 2021-05-27
Q4 2019 $1.94M $1.83M +$1.83M Oct 1, 2019 Dec 31, 2019 10-K/A 2021-04-23
Q3 2019 $113K $100K +$100K Jul 1, 2019 Sep 30, 2019 10-Q 2019-11-14
Q2 2019 $12.6K $0 $0 Apr 1, 2019 Jun 30, 2019 10-Q 2020-11-18
Q1 2019 $12.6K $12.6K +$12.6K Jan 1, 2019 Mar 31, 2019 10-Q 2020-06-30
Q4 2018 $0 $0 Oct 1, 2018 Dec 31, 2018 10-K 2020-05-22
Q3 2018 $0 Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 $0 Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 $0 Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.